Search…

Meinuohua (603538.SH): Sacubitril Valsartan Sodium Tablets Obtained Drug Registration Certificate

17/06/2025

Smart Financial News App, Menova (603538.SH) announced that its wholly-owned subsidiary Ningbo Menova Tiankang Pharmaceutical Co., Ltd. ("Menova Tiankang") recently received the National Medical Products Administration's approved and issued drug registration certificate for Sacubitril Valsartan Sodium Tablets. The indications for this drug are: treatment of primary hypertension; chronic heart failure.

Latest

3 m ago

Slovak natural gas importer SPP said that the EU's plan to terminate the import of Russian natural gas may distort the energy market and threaten supplies to parts of Europe.

5 m ago

Huawei signed a cooperation framework agreement with the People's Government of Huaibei City.

6 m ago

Spot gold has just fallen below $3380.00 per ounce, with the latest price at $3379.95 per ounce, down 0.16% on the day; COMEX gold futures' most recent price is $3398.70 per ounce, down 0.54% on the day.

6 m ago

US stocks of cryptocurrency companies fell, with Coinbase Global down 1.3%, Bitfarms down 3.2%, and Strategy down 1.3%. ProShares Bitcoin Strategy ETF fell 2.8%, while iShares Bitcoin Trust fell 3.1%.

6 m ago

After a drop of over 3% in Bitcoin, stocks related to cryptocurrencies in the US fell. The ProShares Bitcoin Strategy Exchange-Traded Fund dropped 2.8%, and the iShares Bitcoin Trust dropped 3.1%.

See all latest